Prosecution Insights
Last updated: August 18, 2026

Examiner: BEHARRY, ZANNA MARIA

Tech Center 1700 • Art Units: 1631 1632 1791

This examiner grants 23% of resolved cases

Performance Statistics

23.2%
Allow Rate
-41.8% vs TC avg
148
Total Applications
+52.7%
Interview Lift
1510
Avg Prosecution Days
Based on 69 resolved cases, 2023–2026

Rejection Statute Breakdown

5.8%
§101 Eligibility
13.7%
§102 Novelty
45.4%
§103 Obviousness
25.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18694962 USE OF HUMAN MESENCHYMAL STEM CELL SHEET IN TREATMENT OF UTERINE SCARS Non-Final OA BOE Technology Group Co., Ltd.
18563147 LUNG ORGANOID MODEL AND METHOD OF USE Non-Final OA The Regents of the University of California
17286534 Soluble Extracellular Matrix Composition and Method for Intravascular Delivery Final Rejection The Regents of the University of California
17353049 COMPOSITIONS AND METHODS FOR AIRWAY TISSUE REGENERATION Non-Final OA The Board of Trustees of the Leland Stanford Junior University
17433874 METHOD FOR PRODUCING CELL SPHEROIDS Final Rejection NIPPON SHOKUBAI CO., LTD.
17843086 PERFUSION SYSTEM FOR CORNEAL ENDOTHELIAL CELL GRAFT EVALUATION Final Rejection REGENTS OF THE UNIVERSITY OF MINNESOTA
17622102 SYSTEMS AND METHODS RELATING TO THREE-DIMENSIONAL (3D) CELL MANUFACTURING Non-Final OA University of Florida Research Foundation, Inc.
17492137 METHODS OF PROMOTING THYMIC EPITHELIAL CELL AND THYMIC EPITHELIAL CELL PROGENITOR DIFFERENTIATION OF PLURIPOTENT STEM CELLS, RESULTING CELLS, AND USES THEREOF Non-Final OA THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
16992316 Hierarchic Neural Microphysiological System for Brain Function and Disorders Non-Final OA The Trustees of Columbia University in the City of New York
17179643 LACTIC ACID ADSORBENT AND METHOD FOR REMOVING LACTIC ACID Non-Final OA TOHOKU UNIVERSITY
17178470 AMMONIA ADSORBENT AND METHOD FOR REMOVING AMMONIA Non-Final OA TOHOKU UNIVERSITY
17626728 ZEBRAFISH DELETION AND COMPOUND MUTANTS AND USES THEREOF Non-Final OA The General Hospital Corporation
18016266 METHOD FOR PRODUCING CARDIOMYOCYTE SPHEROIDS Final Rejection KANEKA CORPORATION
18286205 COMPOSITIONS AND METHODS FOR TREATMENT OF CRX-MEDIATED RETINOPATHIES Final Rejection Washington University
17617191 RED BLOOD CELL STORAGE SOLUTIONS, ADDITIVES, AND METHODS FOR IMPROVING THE STORAGE OF RED BLOOD CELLS USING INORGANIC PYROPHOSPHATES Final Rejection University of Cincinnati
18029026 PARATHYROID GLAND CELLS Non-Final OA Takeda Pharmaceutical Company Limited
17634148 METHODS FOR MAKING ORGANOID COMPOSITIONS Non-Final OA CHILDREN'S HOSPITAL MEDICAL CENTER
18248739 METHODS FOR MAKING AND USING DIFFERENTIATED NEURAL CELLS Final Rejection Research Development Foundation
18572668 REGULATORY NUCLEIC ACID SEQUENCES Non-Final OA ASKBIO INC.
18525926 PHARMACEUTICAL COMPOSITION COMPRISING ADIPOSE TISSUE-DERIVED EXTRACELLULAR VESICLE AND BIOLOGIC AND USE OF PHARMACEUTICAL COMPOSITION FOR TREATING ARTHRITIS Non-Final OA GWO XI STEM CELL APPLIED TECHNOLOGY CO., LTD
17636422 BIO-PRINTED KIDNEY TISSUE Non-Final OA MURDOCH CHILDREN'S RESEARCH INSTITUTE

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month